...You know there is! EMS World recently published an article which highlights the changing technologies and protocols for managing stroke care. New embolectomy studies such as MR. CLEAN, ESCAPE, EXTEND IA, SWIFT-PRIME, and REVASCAT (see Pulsara's previous post for more details) have shown incredible promise in that patients who recieved the various embolectomy treatments were roughly twice as likely to experience a positive outcome compared to those patients who received IV tPA alone. In fact, all of these studies were stopped early due to efficacy.
